1,3-Butanediol

1,3-Butanediol

SCHEMBL575403

CC(O)CCO.CS(=O)(=O)O.CS(=O)(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of 1,3-Butanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.37
TSHR P16473 3/20 0.33
THRB P10828 1/20 0.33
GRIA1 P42261 3/20 0.31
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Butanediol SCHEMBL5769439 0.92 TP53 (0.43) TDP1ALDH1A1TP53TSHRTHRB
1,3-Butanediol SCHEMBL2166730 0.91 ALDH1A1 (0.33) TDP1ALDH1A1TP53
1,3-Butanediol SCHEMBL2166704 0.91 ALDH1A1 (0.38) TDP1ALDH1A1TP53
1,3-Butanediol SCHEMBL576420 0.87 TP53 (0.40) TDP1ALDH1A1TP53TSHRTHRB
SCHEMBL2858228 0.86 ALDH1A1 (0.42) TDP1ALDH1A1TP53TSHRGRIA1
SCHEMBL9218045 0.86 ALDH1A1 (0.42) TDP1ALDH1A1TP53TSHRGRIA1
1,3-Butanediol SCHEMBL575411 0.83 TP53 (0.33) TDP1ALDH1A1TP53
1,3-Butanediol SCHEMBL575947 0.83 TP53 (0.33) TDP1ALDH1A1TP53
1,3-Butanediol SCHEMBL3427715 0.83 TDP1 (0.53) TDP1ALDH1A1TSHRTHRB
1,3-Butanediol SCHEMBL227565 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673508-B2 Nonaqueous electrolyte for lithium battery and lithium battery using same UBE INDUSTRIES, LTD. (JP) 2014-03-18 US claimed
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
EP-4525123-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME Tomiyama Pure Chemical Industries, Limited (JP) 2025-03-19 EP disclosed
EP-4525122-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME Tomiyama Pure Chemical Industries, Limited (JP) 2025-03-19 EP disclosed
EP-3771014-B1 NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES TOMIYAMA PURE CHEMICAL INDUSTRIES LTD (JP) 2025-03-05 EP disclosed
US-12155037-B2 Nonaqueous electrolyte solution for power storage devices TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2024-11-26 US disclosed
WO-2024225238-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME 富山薬品工業株式会社 2024-10-31 WO disclosed
WO-2024225237-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME 富山薬品工業株式会社 2024-10-31 WO disclosed
US-12107226-B2 Electrolyte for power storage devices and nonaqueous electrolyte solution TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2024-10-01 US disclosed
EP-2108640-A1 ESTER COMPOUND, AND NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY EACH USING THE ESTER COMPOUND Ube Industries, Ltd. (JP) 2009-10-14 EP disclosed
US-20090253045-A1 NONAQUEOUS ELECTROLYTIC SOLUTIONS AND NONAQUEOUS-ELECTROLYTE BATTERIES MITSUBISHI CHEMICAL CORPORATION (JP) 2009-10-08 US disclosed
EP-2031689-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY Mitsubishi Chemical Corporation (JP) 2009-03-04 EP disclosed
US-20080311478-A1 Lithium Secondary Battery MITSUBISHI CHEMICAL CORPORATION (JP) 2008-12-18 US disclosed
EP-1199766-B1 Non-aqueous secondary battery having enhanced discharge capacity retention UBE INDUSTRIES (JP) 2008-05-28 EP disclosed
EP-1892789-A1 LITHIUM SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2008-02-27 EP disclosed
US-20070231707-A1 Nonaqueous Electrolytic Solution and Lithium Secondary Battery MU IONIC SOLUTIONS CORPORATION (JP) 2007-10-04 US disclosed
EP-1772924-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY Ube Industries, Ltd. (JP) 2007-04-11 EP disclosed
US-6436582-B1 A NON-AQUEOUS SOLVENT AND (II) AN ELECTROLYTE SALT DISSOLVED THEREIN AND (III) A DISULFONATE ESTER DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2002-08-20 US disclosed
EP-1199766-A2 Non-aqueous secondary battery having enhanced discharge capacity retention Ube Industries, Ltd. (JP) 2002-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME SMC1A, SMC2, SMC4 TDP1 1786/4885ALDH1A1 3714/4885TP53 4091/4885
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME KCNN1, KCNN2, ILK TDP1 1480/4885ALDH1A1 3090/4885TP53 3779/4885
US-12155037-B2 Nonaqueous electrolyte solution for power storage devices AQP1, NCS1, SLC9A1 TDP1 2873/4885ALDH1A1 1681/4885TP53 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.